Facial Plast Surg 2023; 39(02): 190-200
DOI: 10.1055/a-1950-4483
Original Research

Selective Neurectomy for Treatment of Post-Facial Paralysis Synkinesis: A Systematic Review

1   Department of Otorhinolaryngology- Head and Neck Surgery, University of Maryland Medical System, Baltimore, Maryland
,
Kelly Bridgham
2   Department of Otorhinolaryngology- Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
3   University of Maryland School of Medicine, Baltimore, Maryland
,
Emilie Ludeman
4   Health Sciences and Human Services Library, University of Maryland Graduate School, Baltimore, Maryland
,
Kalpesh Vakharia
1   Department of Otorhinolaryngology- Head and Neck Surgery, University of Maryland Medical System, Baltimore, Maryland
3   University of Maryland School of Medicine, Baltimore, Maryland
,
Natalie Justicz
1   Department of Otorhinolaryngology- Head and Neck Surgery, University of Maryland Medical System, Baltimore, Maryland
3   University of Maryland School of Medicine, Baltimore, Maryland
› Author Affiliations
Funding None.

Abstract

Background Synkinesis is commonly encountered after flaccid facial paralysis and can have a detrimental impact on a patient's life. First-line treatment of synkinesis is chemodenervation with botulinum toxin (Botox) and neuromuscular retraining. Surgical options include selective myectomy, selective neurectomy (SN), cross-facial nerve grafting, nerve substitution, and free gracilis muscle transfer. Data on surgical management of synkinesis using SN is limited.

Evidence Review PubMed, Embase, Cochrane CENTRAL, Cochrane Neuromuscular Register, Clinicaltrials.gov, and World Health Organization International Clinical Trials Registry Platform were searched using a comprehensive keyword strategy in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. All English-only texts published in the past 20 years were included. Two independent investigators reviewed 906 abstracts and 7 studies met inclusion criteria. Demographics, etiology of paralysis, time to surgery, and primary outcomes studied were collected.

Findings A total of 250 patients were included across 7 studies. In 6 out of 7 studies, Botox was used prior to surgical intervention. Two studies showed significant reduction in Botox dosage postoperatively, while one study showed no difference. Other primary outcomes included the House–Brackmann Score, palpebral fissure width, electronic clinician-graded facial function scale (eFACE) score, Facial Clinimetric Evaluation (FaCE) scale, and Synkinesis Assessment Questionnaire (SAQ). Three studies showed significant improvement in the eFACE score, two studies showed significant improvement in the FaCE scale, while one study showed improvement in quality of life measured by the SAQ.

Conclusion SN can be considered as an adjunct to other management options including neuromuscular retraining, Botox, selective myectomy, and reanimation procedures. While there is great heterogeneity of study design in the studies included, many cohorts showed improvement in facial symmetry, facial function, and quality of life. There remains a great gap in knowledge in this subject matter and a need for large well-designed prospective studies comparing this technique to other management options.

Note

This abstract was accepted for poster presentation at the AAFPRS International Symposium of Facial Plastic Surgery, National Harbor, MD, 10/20/22–10/23/22.


Author Disclosure Statement

The authors whose names are listed certify that they have no affiliations with or involvement in any organization or entity with any financial interest or nonfinancial interest in the subject matter or materials discussed in this manuscript.




Publication History

Accepted Manuscript online:
25 September 2022

Article published online:
03 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Dey JK, Ishii LE, Nellis JC, Boahene KDO, Byrne PJ, Ishii M. Comparing patient, casual observer, and expert perception of permanent unilateral facial paralysis. JAMA Facial Plast Surg 2017; 19 (06) 476-483
  • 2 Goines JB, Ishii LE, Dey JK. et al. Association of facial paralysis-related disability with patient- and observer-perceived quality of life. JAMA Facial Plast Surg 2016; 18 (05) 363-369
  • 3 Parsa KM, Hancock M, Nguy PL. et al. Association of facial paralysis with perceptions of personality and physical traits. JAMA Netw Open 2020; 3 (06) e205495
  • 4 Nellis JC, Ishii M, Byrne PJ, Boahene KDO, Dey JK, Ishii LE. Association among facial paralysis, depression, and quality of life in facial plastic surgery patients. JAMA Facial Plast Surg 2017; 19 (03) 190-196
  • 5 Ishii L, Godoy A, Encarnacion CO, Byrne PJ, Boahene KDO, Ishii M. Not just another face in the crowd: society's perceptions of facial paralysis. Laryngoscope 2012; 122 (03) 533-538
  • 6 Dey JK, Ishii M, Boahene KDO, Byrne PJ, Ishii LE. Changing perception: facial reanimation surgery improves attractiveness and decreases negative facial perception. Laryngoscope 2014; 124 (01) 84-90
  • 7 Kleiss IJ, Hohman MH, Susarla SM, Marres HAM, Hadlock TA. Health-related quality of life in 794 patients with a peripheral facial palsy using the FaCE Scale: a retrospective cohort study. Clin Otolaryngol 2015; 40 (06) 651-656
  • 8 Ho AL, Scott AM, Klassen AF, Cano SJ, Pusic AL, Van Laeken N. Measuring quality of life and patient satisfaction in facial paralysis patients: a systematic review of patient-reported outcome measures. Plast Reconstr Surg 2012; 130 (01) 91-99
  • 9 Krane NA, Genther D, Weierich K. et al. Degree of self-reported facial impairment correlates with social impairment in individuals with facial paralysis and synkinesis. Facial Plast Surg Aesthet Med 2020; 22 (05) 362-369
  • 10 Fu L, Bundy C, Sadiq SA. Psychological distress in people with disfigurement from facial palsy. Eye (Lond) 2011; 25 (10) 1322-1326
  • 11 Lee J, Fung K, Lownie SP, Parnes LS. Assessing impairment and disability of facial paralysis in patients with vestibular schwannoma. Arch Otolaryngol Head Neck Surg 2007; 133 (01) 56-60
  • 12 Yamamoto E, Nishimura H, Hirono Y. Occurrence of sequelae in Bell's palsy. Acta Otolaryngol Suppl 1988; 446 (S446): 93-96
  • 13 Nash JJ, Friedland DR, Boorsma KJ, Rhee JS. Management and outcomes of facial paralysis from intratemporal blunt trauma: a systematic review. Laryngoscope 2010; 120 (07) 1397-1404
  • 14 Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope 2014; 124 (07) E283-E293
  • 15 Takeda T, Takeda S, Okada T, Kakigi A, Yamasoba T. Experimental studies on the recovery processes from severe facial palsy and the development of its sequelae. Otol Neurotol 2015; 36 (05) 896-903
  • 16 Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope 1996; 106 (12 Pt 1): 1491-1496
  • 17 Brach JS, VanSwearingen J, Delitto A, Johnson PC. Impairment and disability in patients with facial neuromuscular dysfunction. Otolaryngol Head Neck Surg 1997; 117 (04) 315-321
  • 18 Çelik M, Forta H, Vural C. The development of synkinesis after facial nerve paralysis. Eur Neurol 2000; 43 (03) 147-151
  • 19 Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope 2007; 117 (05) 923-926
  • 20 Shtraks JP, Mirocha J, Azizzadeh B. Quality of life outcomes after modified selective neurectomy for postfacial paralysis synkinesis. Facial Plast Surg Aesthet Med 2021; 23 (06) 443-448
  • 21 Azizzadeh B, Irvine LE, Diels J. et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg 2019; 143 (05) 1483-1496
  • 22 Schmidt KL, Cohn JF. Human facial expressions as adaptations: evolutionary questions in facial expression research. Am J Phys Anthropol 2001; (Suppl. 33) 3-24
  • 23 Otta E, Folladore Abrosio F, Hoshino RL. Reading a smiling face: messages conveyed by various forms of smiling. Percept Mot Skills 1996; 82 (3 Pt 2): 1111-1121
  • 24 Helwig NE, Sohre NE, Ruprecht MR, Guy SJ, Lyford-Pike S. Dynamic properties of successful smiles. PLoS One 2017; 12 (06) e0179708
  • 25 Miller MQ, Hadlock TA. Deep dive into denervation: institutional experience with selective denervation in nonflaccid facial palsy. Facial Plast Surg Aesthet Med 2021; 23 (04) 241-247
  • 26 Cabin JA, Massry GG, Azizzadeh B. Botulinum toxin in the management of facial paralysis. Curr Opin Otolaryngol Head Neck Surg 2015; 23 (04) 272-280
  • 27 Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg 2012; 129 (06) 925e-939e
  • 28 Lindsay RW, Robinson M, Hadlock TA. Comprehensive facial rehabilitation improves function in people with facial paralysis: a 5-year experience at the Massachusetts Eye and Ear Infirmary. Phys Ther 2010; 90 (03) 391-397
  • 29 Miller MQ, Hadlock TA. Beyond Botox: contemporary management of nonflaccid facial palsy. Facial Plast Surg Aesthet Med 2020; 22 (02) 65-70
  • 30 Jowett N, Malka R, Hadlock TA. Effect of weakening of ipsilateral depressor anguli oris on smile symmetry in postparalysis facial palsy. JAMA Facial Plast Surg 2017; 19 (01) 29-33
  • 31 Jowett N, Hadlock TA. An evidence-based approach to facial reanimation. Facial Plast Surg Clin North Am 2015; 23 (03) 313-334
  • 32 Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 2012; 122 (02) 266-270
  • 33 Biglioli F, Kutanovaite O, Rabbiosi D. et al. Surgical treatment of synkinesis between smiling and eyelid closure. J Craniomaxillofac Surg 2017; 45 (12) 1996-2001
  • 34 Lindsay RW, Bhama P, Hadlock TA. Quality-of-life improvement after free gracilis muscle transfer for smile restoration in patients with facial paralysis. JAMA Facial Plast Surg 2014; 16 (06) 419-424
  • 35 Henstrom DK, Malo JS, Cheney ML, Hadlock TA. Platysmectomy: an effective intervention for facial synkinesis and hypertonicity. Arch Facial Plast Surg 2011; 13 (04) 239-243
  • 36 Azizzadeh B, Hjelm N. Modified selective neurectomy: a new paradigm in the management of facial palsy with synkinesis. Facial Plast Surg Clin North Am 2021; 29 (03) 453-457
  • 37 Azizzadeh B, Frisenda JL. Surgical management of postparalysis facial palsy and synkinesis. Otolaryngol Clin North Am 2018; 51 (06) 1169-1178
  • 38 Vincent AG, Bevans SE, Robitschek JM, Wind GG, Hohman MH. Masseteric-to-facial nerve transfer and selective neurectomy for rehabilitation of the synkinetic smile. JAMA Facial Plast Surg 2019; 21 (06) 504-510
  • 39 Coleman CC. Surgical treatment of facial spasm. Ann Surg 1937; 105 (05) 647-657
  • 40 Greenwood Jr J. The surgical treatment of hemifacial spasm. J Neurosurg 1946; 3 (06) 506-510
  • 41 Marino H, Alurralde A. Spastic facial palsy; peripheral selective neurotomy. Br J Plast Surg 1950; 3 (01) 56-59
  • 42 Chuang DCC, Chang TNJ, Lu JCY. Postparalysis facial synkinesis: clinical classification and surgical strategies. Plast Reconstr Surg Glob Open 2015; 3 (03) e320
  • 43 Hohman MH, Lee LN, Hadlock TA. Two-step highly selective neurectomy for refractory periocular synkinesis. Laryngoscope 2013; 123 (06) 1385-1388
  • 44 Yang SF, Xie Y, Kim JC. Use of local anesthetic injections in the evaluation of facial synkinesis. Facial Plast Surg Aesthet Med 2022; 24 (01) 60
  • 45 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological Index for Non-Randomized Studies (MINORS): development and validation of a new instrument. ANZ J Surg 2003; 73 (09) 712-716
  • 46 Marvin K, Coulter M, Johnson C, Friesen T, Morris K, Brigger MT. Dysphagia outcomes following surgical management of unilateral vocal fold immobility in children: a systematic review. Otolaryngol Head Neck Surg 2022; 1945998221084891
  • 47 Fattah AY, Gurusinghe ADR, Gavilan J. et al; Sir Charles Bell Society. Facial nerve grading instruments: systematic review of the literature and suggestion for uniformity. Plast Reconstr Surg 2015; 135 (02) 569-579
  • 48 Banks CA, Bhama PK, Park J, Hadlock CR, Hadlock TA. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg 2015; 136 (02) 223e-230e
  • 49 Banks CA, Jowett N, Hadlock TA. Test-retest reliability and agreement between in-person and video assessment of facial mimetic function using the eFACE facial grading system. JAMA Facial Plast Surg 2017; 19 (03) 206-211
  • 50 Kahn JB, Gliklich RE, Boyev KP, Stewart MG, Metson RB, McKenna MJ. Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale. Laryngoscope 2001; 111 (03) 387-398
  • 51 van Veen MM, Dusseldorp JR, Hadlock TA. Long-term outcome of selective neurectomy for refractory periocular synkinesis. Laryngoscope 2018; 128 (10) 2291-2295
  • 52 Hjelm N, Crippen M, Azizzadeh B. Long-term changes in the treatment pattern of botulinum toxin A injections for postfacial paralysis synkinesis following modified selective neurectomy. Facial Plast Surg Aesthet Med 2021; 23 (03) 234-235
  • 53 Salles AG, da Costa EF, Ferreira MC, do Nascimento Remigio AF, Moraes LB, Gemperli R. Epidemiologic overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. Plast Reconstr Surg 2015; 136 (06) 1289-1298
  • 54 Li MKK, Niles N, Gore S, Ebrahimi A, McGuinness J, Clark JR. Social perception of morbidity in facial nerve paralysis. Head Neck 2016; 38 (08) 1158-1163